702-1082

withdrawn

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
702 (USA) · Dr. Nolan
consented 2013-07-26

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-09-09 (study day 46.0); relationship: PROBABLE

mild assessed

Mild NEUTROPHIL COUNT INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed

Mild NEUTROPHIL COUNT INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed

Mild RECTAL HAEMORRHAGE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-02 (study day 39.0); relationship: NONE

mild assessed

Mild RECTAL HAEMORRHAGE — outcome: RECOVERED/RESOLVED; onset 2013-09-02 (study day 39.0); relationship: NONE

moderate assessed

Moderate SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 79.0); relationship: PROBABLE

mild assessed

Mild URINE ANALYSIS ABNORMAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed

Mild URINE ANALYSIS ABNORMAL — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed

Mild WHITE BLOOD CELL COUNT INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed

Mild WHITE BLOOD CELL COUNT INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

Data queries

No data queries.